These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12430864)

  • 1. Role of NKT cells and alpha-galactosyl ceramide.
    Shimosaka A
    Int J Hematol; 2002 Aug; 76 Suppl 1():277-9. PubMed ID: 12430864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation.
    Trobonjaca Z; Kröger A; Stober D; Leithäuser F; Möller P; Hauser H; Schirmbeck R; Reimann J
    J Immunol; 2002 Apr; 168(8):3763-70. PubMed ID: 11937527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRN7000 Reduces Airway Inflammation via Natural Killer T Cells in Obese Asthmatic Mice.
    Chen Y; Zhu Y; Su G; Yang W; Zhao Y; Lu W; Zhang J
    Inflammation; 2021 Oct; 44(5):1982-1992. PubMed ID: 34021838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
    Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
    J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.
    Chang DH; Osman K; Connolly J; Kukreja A; Krasovsky J; Pack M; Hutchinson A; Geller M; Liu N; Annable R; Shay J; Kirchhoff K; Nishi N; Ando Y; Hayashi K; Hassoun H; Steinman RM; Dhodapkar MV
    J Exp Med; 2005 May; 201(9):1503-17. PubMed ID: 15867097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
    Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
    Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.
    Ishikawa E; Motohashi S; Ishikawa A; Ito T; Uchida T; Kaneko T; Tanaka Y; Horiguchi S; Okamoto Y; Fujisawa T; Tsuboi K; Taniguchi M; Matsumura A; Nakayama T
    Int J Cancer; 2005 Nov; 117(2):265-73. PubMed ID: 15900581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
    Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
    J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells.
    Trobonjaca Z; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 2001 Aug; 167(3):1413-22. PubMed ID: 11466360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
    Eberl G; MacDonald HR
    Eur J Immunol; 2000 Apr; 30(4):985-92. PubMed ID: 10760785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
    Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
    Minagawa M; Iiai T; Sato Y; Yamamoto S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1553-5. PubMed ID: 16315866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
    Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.
    Macho Fernandez E; Chang J; Fontaine J; Bialecki E; Rodriguez F; Werkmeister E; Krieger V; Ehret C; Heurtault B; Fournel S; Frisch B; Betbeder D; Faveeuw C; Trottein F
    Int J Pharm; 2012 Feb; 423(1):45-54. PubMed ID: 21575695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
    Godó M; Sessler T; Hamar P
    Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
    Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
    J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S; Shimizu K; Hemmi H; Steinman RM
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor immunity produced by the liver Kupffer cells, NK cells, NKT cells, and CD8 CD122 T cells.
    Seki S; Nakashima H; Nakashima M; Kinoshita M
    Clin Dev Immunol; 2011; 2011():868345. PubMed ID: 22190974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.